Idarucizumab for Dabigatran Reversal-full Cohort Analysis (RE-VERSE AD Study)Esme EkizoğluIstanbul University Istanbul Faculty of Medicine, Department of Neurology, Istanbul, Turkey
Keywords: Dabigatran, idarucizumab, reversal
Esme Ekizoğlu. Idarucizumab for Dabigatran Reversal-full Cohort Analysis (RE-VERSE AD Study). Turk J Neurol. 2018; 24(2): 199-200
Corresponding Author: Esme Ekizoğlu, Türkiye |
|
English Full Text
Print
Download citation
RIS
Share with email
Share
Send email to author
PubMed